Total properties:
86
|
|
Patent #:
|
|
Issue Dt:
|
10/02/2001
|
Application #:
|
08486673
|
Filing Dt:
|
06/07/1995
|
Title:
|
NUCLEIC ACIDS ENCODING THE C 140 RECEPTOR
|
|
|
Patent #:
|
|
Issue Dt:
|
12/03/2002
|
Application #:
|
09231759
|
Filing Dt:
|
01/15/1999
|
Title:
|
ANTI-CCR4 ANTIBODIES AND METHODS OF USE THEREFOR
|
|
|
Patent #:
|
|
Issue Dt:
|
05/30/2006
|
Application #:
|
10272899
|
Filing Dt:
|
10/17/2002
|
Publication #:
|
|
Pub Dt:
|
02/19/2004
| | | | |
Title:
|
IMMUNOGLOBULIN DNA CASSETTE MOLECULES, MONOBODY CONSTRUCTS, METHODS OF PRODUCTION, AND METHODS OF USE THEREFOR
|
|
|
Patent #:
|
|
Issue Dt:
|
07/03/2007
|
Application #:
|
10443155
|
Filing Dt:
|
05/21/2003
|
Publication #:
|
|
Pub Dt:
|
02/26/2004
| | | | |
Title:
|
CCR9 INHIBITORS AND METHODS OF USE THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
05/01/2007
|
Application #:
|
10678872
|
Filing Dt:
|
10/03/2003
|
Publication #:
|
|
Pub Dt:
|
04/29/2004
| | | | |
Title:
|
PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
|
|
|
Patent #:
|
|
Issue Dt:
|
05/27/2008
|
Application #:
|
10744585
|
Filing Dt:
|
12/23/2003
|
Publication #:
|
|
Pub Dt:
|
10/21/2004
| | | | |
Title:
|
CCR8 INHIBITORS
|
|
|
Patent #:
|
|
Issue Dt:
|
06/01/2010
|
Application #:
|
10821545
|
Filing Dt:
|
04/09/2004
|
Publication #:
|
|
Pub Dt:
|
11/25/2004
| | | | |
Title:
|
BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE
|
|
|
Patent #:
|
|
Issue Dt:
|
02/17/2009
|
Application #:
|
10891362
|
Filing Dt:
|
07/14/2004
|
Publication #:
|
|
Pub Dt:
|
04/21/2005
| | | | |
Title:
|
ARYL SULFONAMIDES USEFUL AS INHIBITORS OF CHEMOKINE RECEPTOR ACTIVITY
|
|
|
Patent #:
|
|
Issue Dt:
|
03/17/2009
|
Application #:
|
11101208
|
Filing Dt:
|
04/07/2005
|
Publication #:
|
|
Pub Dt:
|
11/17/2005
| | | | |
Title:
|
PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
|
|
|
Patent #:
|
|
Issue Dt:
|
05/31/2011
|
Application #:
|
11101998
|
Filing Dt:
|
04/08/2005
|
Publication #:
|
|
Pub Dt:
|
10/27/2005
| | | | |
Title:
|
BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE
|
|
|
Patent #:
|
|
Issue Dt:
|
05/31/2011
|
Application #:
|
11346469
|
Filing Dt:
|
02/02/2006
|
Publication #:
|
|
Pub Dt:
|
08/24/2006
| | | | |
Title:
|
SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES AS INHIBITORS OF E1 ACTIVATING ENZYMES
|
|
|
Patent #:
|
|
Issue Dt:
|
05/31/2011
|
Application #:
|
11360885
|
Filing Dt:
|
02/23/2006
|
Publication #:
|
|
Pub Dt:
|
10/26/2006
| | | | |
Title:
|
PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
|
|
|
Patent #:
|
|
Issue Dt:
|
10/16/2007
|
Application #:
|
11391633
|
Filing Dt:
|
03/28/2006
|
Publication #:
|
|
Pub Dt:
|
07/27/2006
| | | | |
Title:
|
CCR9 INHIBITORS AND METHODS OF USE THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
02/07/2012
|
Application #:
|
11636609
|
Filing Dt:
|
12/07/2006
|
Publication #:
|
|
Pub Dt:
|
06/28/2007
| | | | |
Title:
|
BICYCLIC COMPOUNDS WITH KINASE INHIBITORY ACTIVITY
|
|
|
Patent #:
|
|
Issue Dt:
|
06/26/2012
|
Application #:
|
11700614
|
Filing Dt:
|
01/31/2007
|
Publication #:
|
|
Pub Dt:
|
08/16/2007
| | | | |
Title:
|
INHIBITORS OF E1 ACTIVATING ENZYMES
|
|
|
Patent #:
|
|
Issue Dt:
|
08/30/2011
|
Application #:
|
11890338
|
Filing Dt:
|
08/06/2007
|
Publication #:
|
|
Pub Dt:
|
02/28/2008
| | | | |
Title:
|
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
|
|
|
Patent #:
|
|
Issue Dt:
|
05/18/2010
|
Application #:
|
11890406
|
Filing Dt:
|
08/06/2007
|
Publication #:
|
|
Pub Dt:
|
02/21/2008
| | | | |
Title:
|
PYRIDOBENZAZEPINE COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION
|
|
|
Patent #:
|
|
Issue Dt:
|
01/13/2015
|
Application #:
|
12221399
|
Filing Dt:
|
08/01/2008
|
Publication #:
|
|
Pub Dt:
|
02/05/2009
| | | | |
Title:
|
PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS
|
|
|
Patent #:
|
|
Issue Dt:
|
03/04/2014
|
Application #:
|
12586650
|
Filing Dt:
|
09/25/2009
|
Publication #:
|
|
Pub Dt:
|
04/01/2010
| | | | |
Title:
|
DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBORONIC ACID
|
|
|
Patent #:
|
|
Issue Dt:
|
08/16/2011
|
Application #:
|
12631144
|
Filing Dt:
|
12/04/2009
|
Publication #:
|
|
Pub Dt:
|
07/15/2010
| | | | |
Title:
|
THIOLACTAMS AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
08/16/2011
|
Application #:
|
12640439
|
Filing Dt:
|
12/17/2009
|
Publication #:
|
|
Pub Dt:
|
04/15/2010
| | | | |
Title:
|
CCR9 INHIBITORS AND METHODS OF USE THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
06/17/2014
|
Application #:
|
12694230
|
Filing Dt:
|
01/26/2010
|
Publication #:
|
|
Pub Dt:
|
09/16/2010
| | | | |
Title:
|
HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR
|
|
|
Patent #:
|
|
Issue Dt:
|
11/17/2015
|
Application #:
|
12779331
|
Filing Dt:
|
05/13/2010
|
Publication #:
|
|
Pub Dt:
|
01/27/2011
| | | | |
Title:
|
HYDROCHLORIDE SALT OF((1S,2S,4R)-4-{4-[(1S)-
2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-
PYRROLO[2,3-D]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL)METHYL SULFAMATE
|
|
|
Patent #:
|
|
Issue Dt:
|
04/08/2014
|
Application #:
|
13163592
|
Filing Dt:
|
06/17/2011
|
Publication #:
|
|
Pub Dt:
|
01/12/2012
| | | | |
Title:
|
D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE
|
|
|
Patent #:
|
|
Issue Dt:
|
09/18/2012
|
Application #:
|
13173161
|
Filing Dt:
|
06/30/2011
|
Publication #:
|
|
Pub Dt:
|
10/20/2011
| | | | |
Title:
|
THIOLACTAMS AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
07/09/2013
|
Application #:
|
13216352
|
Filing Dt:
|
08/24/2011
|
Publication #:
|
|
Pub Dt:
|
03/22/2012
| | | | |
Title:
|
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
|
|
|
Patent #:
|
|
Issue Dt:
|
08/13/2013
|
Application #:
|
13570486
|
Filing Dt:
|
08/09/2012
|
Publication #:
|
|
Pub Dt:
|
12/06/2012
| | | | |
Title:
|
THIOLACTAMS AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
08/19/2014
|
Application #:
|
13592389
|
Filing Dt:
|
08/23/2012
|
Publication #:
|
|
Pub Dt:
|
06/13/2013
| | | | |
Title:
|
INHIBITORS OF NEDD8-ACTIVATING ENZYME
|
|
|
Patent #:
|
|
Issue Dt:
|
11/18/2014
|
Application #:
|
13600260
|
Filing Dt:
|
08/31/2012
|
Publication #:
|
|
Pub Dt:
|
01/10/2013
| | | | |
Title:
|
METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY
|
|
|
Patent #:
|
|
Issue Dt:
|
03/17/2015
|
Application #:
|
13667641
|
Filing Dt:
|
11/02/2012
|
Publication #:
|
|
Pub Dt:
|
05/09/2013
| | | | |
Title:
|
ADMINISTRATION OF A NEDD8-ACTIVATING ENZYME INHIBITOR AND HYPOMETHYLATING AGENT
|
|
|
Patent #:
|
|
Issue Dt:
|
03/22/2016
|
Application #:
|
13767314
|
Filing Dt:
|
02/14/2013
|
Publication #:
|
|
Pub Dt:
|
03/27/2014
| | | | |
Title:
|
PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME
|
|
|
Patent #:
|
|
Issue Dt:
|
04/07/2015
|
Application #:
|
13872080
|
Filing Dt:
|
04/27/2013
|
Publication #:
|
|
Pub Dt:
|
10/31/2013
| | | | |
Title:
|
ANTI-GCC ANTIBODY MOLECULES AND METHODS FOR USE OF SAME
|
|
|
Patent #:
|
|
Issue Dt:
|
12/02/2014
|
Application #:
|
13911415
|
Filing Dt:
|
06/06/2013
|
Publication #:
|
|
Pub Dt:
|
10/09/2014
| | | | |
Title:
|
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
|
|
|
Patent #:
|
|
Issue Dt:
|
05/19/2015
|
Application #:
|
14049452
|
Filing Dt:
|
10/09/2013
|
Publication #:
|
|
Pub Dt:
|
04/17/2014
| | | | |
Title:
|
CCR9 INHIBITORS AND METHODS OF USE THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
09/26/2017
|
Application #:
|
14153752
|
Filing Dt:
|
01/13/2014
|
Publication #:
|
|
Pub Dt:
|
07/10/2014
| | | | |
Title:
|
DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBORONIC ACID
|
|
|
Patent #:
|
|
Issue Dt:
|
10/13/2015
|
Application #:
|
14184615
|
Filing Dt:
|
02/19/2014
|
Publication #:
|
|
Pub Dt:
|
11/27/2014
| | | | |
Title:
|
D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE
|
|
|
Patent #:
|
|
Issue Dt:
|
05/31/2016
|
Application #:
|
14271107
|
Filing Dt:
|
05/06/2014
|
Publication #:
|
|
Pub Dt:
|
09/25/2014
| | | | |
Title:
|
HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR
|
|
|
Patent #:
|
|
Issue Dt:
|
12/26/2017
|
Application #:
|
14326051
|
Filing Dt:
|
07/08/2014
|
Publication #:
|
|
Pub Dt:
|
01/08/2015
| | | | |
Title:
|
INHIBITORS OF NEDD8-ACTIVATING ENZYME
|
|
|
Patent #:
|
|
Issue Dt:
|
03/20/2018
|
Application #:
|
14356974
|
Filing Dt:
|
05/08/2014
|
Publication #:
|
|
Pub Dt:
|
06/04/2015
| | | | |
Title:
|
BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORS
|
|
|
Patent #:
|
|
Issue Dt:
|
03/14/2017
|
Application #:
|
14419000
|
Filing Dt:
|
02/02/2015
|
Publication #:
|
|
Pub Dt:
|
07/30/2015
| | | | |
Title:
|
INDOLE-SUBSTITUTED PYRROLOPYRIMIDINYL INHIBITORS OF UBA6
|
|
|
Patent #:
|
|
Issue Dt:
|
05/26/2020
|
Application #:
|
14432587
|
Filing Dt:
|
03/31/2015
|
Publication #:
|
|
Pub Dt:
|
08/27/2015
| | | | |
Title:
|
BIOMARKERS AND METHODS TO PREDICT RESPONSE TO INHIBITORS AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
10/06/2015
|
Application #:
|
14480513
|
Filing Dt:
|
09/08/2014
|
Publication #:
|
|
Pub Dt:
|
07/02/2015
| | | | |
Title:
|
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
|
|
|
Patent #:
|
|
Issue Dt:
|
05/08/2018
|
Application #:
|
14516719
|
Filing Dt:
|
10/17/2014
|
Publication #:
|
|
Pub Dt:
|
09/10/2015
| | | | |
Title:
|
METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY
|
|
|
Patent #:
|
|
Issue Dt:
|
10/31/2017
|
Application #:
|
14552883
|
Filing Dt:
|
11/25/2014
|
Publication #:
|
|
Pub Dt:
|
12/10/2015
| | | | |
Title:
|
SULFAMOYLATING REAGENTS
|
|
|
Patent #:
|
|
Issue Dt:
|
10/31/2017
|
Application #:
|
14596052
|
Filing Dt:
|
01/13/2015
|
Publication #:
|
|
Pub Dt:
|
08/13/2015
| | | | |
Title:
|
HETEROARYLS AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
03/01/2016
|
Application #:
|
14634438
|
Filing Dt:
|
02/27/2015
|
Title:
|
ANTI-GCC ANTIBODY MOLECULES AND METHODS FOR USE OF SAME
|
|
|
Patent #:
|
|
Issue Dt:
|
06/20/2017
|
Application #:
|
14788675
|
Filing Dt:
|
06/30/2015
|
Publication #:
|
|
Pub Dt:
|
01/05/2017
| | | | |
Title:
|
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
|
|
|
Patent #:
|
|
Issue Dt:
|
10/04/2016
|
Application #:
|
14827556
|
Filing Dt:
|
08/17/2015
|
Publication #:
|
|
Pub Dt:
|
02/11/2016
| | | | |
Title:
|
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
|
|
|
Patent #:
|
|
Issue Dt:
|
07/10/2018
|
Application #:
|
14879151
|
Filing Dt:
|
10/09/2015
|
Publication #:
|
|
Pub Dt:
|
01/05/2017
| | | | |
Title:
|
HYDROCHLORIDE SALT OF((1S,2S,4R)-4-{4-[(1S)- 2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H- PYRROLO[2,3-D]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL) METHYL SULFAMATE
|
|
|
Patent #:
|
|
Issue Dt:
|
07/04/2017
|
Application #:
|
14901809
|
Filing Dt:
|
12/29/2015
|
Publication #:
|
|
Pub Dt:
|
12/08/2016
| | | | |
Title:
|
HETEROARYL INHIBITORS OF SUMO ACTIVATING ENZYME
|
|
|
Patent #:
|
|
Issue Dt:
|
07/04/2017
|
Application #:
|
15025906
|
Filing Dt:
|
03/30/2016
|
Publication #:
|
|
Pub Dt:
|
07/28/2016
| | | | |
Title:
|
INHIBITOR OF BREAST CANCER RESISTANCE PROTEIN (BCRP)
|
|
|
Patent #:
|
|
Issue Dt:
|
05/30/2017
|
Application #:
|
15048007
|
Filing Dt:
|
02/19/2016
|
Publication #:
|
|
Pub Dt:
|
08/25/2016
| | | | |
Title:
|
PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME
|
|
|
Patent #:
|
|
Issue Dt:
|
02/12/2019
|
Application #:
|
15111429
|
Filing Dt:
|
07/13/2016
|
Publication #:
|
|
Pub Dt:
|
11/17/2016
| | | | |
Title:
|
HETEROARYLS AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
08/01/2017
|
Application #:
|
15249851
|
Filing Dt:
|
08/29/2016
|
Publication #:
|
|
Pub Dt:
|
02/23/2017
| | | | |
Title:
|
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES
|
|
|
Patent #:
|
|
Issue Dt:
|
09/05/2017
|
Application #:
|
15347334
|
Filing Dt:
|
11/09/2016
|
Publication #:
|
|
Pub Dt:
|
03/16/2017
| | | | |
Title:
|
HETEROARYLS AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
05/08/2018
|
Application #:
|
15488795
|
Filing Dt:
|
04/17/2017
|
Publication #:
|
|
Pub Dt:
|
08/03/2017
| | | | |
Title:
|
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
|
|
|
Patent #:
|
|
Issue Dt:
|
10/24/2017
|
Application #:
|
15488800
|
Filing Dt:
|
04/17/2017
|
Publication #:
|
|
Pub Dt:
|
08/03/2017
| | | | |
Title:
|
PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME
|
|
|
Patent #:
|
|
Issue Dt:
|
07/02/2019
|
Application #:
|
15522717
|
Filing Dt:
|
04/27/2017
|
Publication #:
|
|
Pub Dt:
|
11/23/2017
| | | | |
Title:
|
ADMINISTRATION OF UBIQUITIN-ACTIVATING ENZYME INHIBITOR AND RADIATION
|
|
|
Patent #:
|
|
Issue Dt:
|
09/11/2018
|
Application #:
|
15550132
|
Filing Dt:
|
08/10/2017
|
Publication #:
|
|
Pub Dt:
|
02/15/2018
| | | | |
Title:
|
NOVEL CRYSTALLINE FORM OF A PROTEASOME INHIBITOR
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15551093
|
Filing Dt:
|
08/15/2017
|
Publication #:
|
|
Pub Dt:
|
08/23/2018
| | | | |
Title:
|
COMBINATION THERAPY FOR CANCER TREATMENT
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15556186
|
Filing Dt:
|
09/06/2017
|
Publication #:
|
|
Pub Dt:
|
02/22/2018
| | | | |
Title:
|
METHOD OF TREATING PRIMARY SCLEROSING CHOLANGITIS
|
|
|
Patent #:
|
|
Issue Dt:
|
01/21/2020
|
Application #:
|
15665506
|
Filing Dt:
|
08/01/2017
|
Publication #:
|
|
Pub Dt:
|
05/03/2018
| | | | |
Title:
|
HETEROARYLS AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
07/31/2018
|
Application #:
|
15680514
|
Filing Dt:
|
08/18/2017
|
Publication #:
|
|
Pub Dt:
|
12/07/2017
| | | | |
Title:
|
DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBORONIC ACID
|
|
|
Patent #:
|
|
Issue Dt:
|
02/12/2019
|
Application #:
|
15699818
|
Filing Dt:
|
09/08/2017
|
Publication #:
|
|
Pub Dt:
|
12/28/2017
| | | | |
Title:
|
PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME
|
|
|
Patent #:
|
|
Issue Dt:
|
08/18/2020
|
Application #:
|
15713293
|
Filing Dt:
|
09/22/2017
|
Publication #:
|
|
Pub Dt:
|
03/22/2018
| | | | |
Title:
|
PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS
|
|
|
Patent #:
|
|
Issue Dt:
|
07/02/2019
|
Application #:
|
15923015
|
Filing Dt:
|
03/16/2018
|
Publication #:
|
|
Pub Dt:
|
11/01/2018
| | | | |
Title:
|
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
|
|
|
Patent #:
|
|
Issue Dt:
|
09/29/2020
|
Application #:
|
15980165
|
Filing Dt:
|
05/15/2018
|
Publication #:
|
|
Pub Dt:
|
11/15/2018
| | | | |
Title:
|
ADMINISTRATION OF NEDD8-ACTIVATING ENZYME INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15997158
|
Filing Dt:
|
06/04/2018
|
Publication #:
|
|
Pub Dt:
|
11/15/2018
| | | | |
Title:
|
METHODS FOR THE HARVESTING OF CELL CULTURES
|
|
|
Patent #:
|
|
Issue Dt:
|
05/23/2023
|
Application #:
|
16086405
|
Filing Dt:
|
09/19/2018
|
Publication #:
|
|
Pub Dt:
|
04/04/2019
| | | | |
Title:
|
ALGINATE HYDROGEL COMPOSITIONS
|
|
|
Patent #:
|
|
Issue Dt:
|
09/19/2023
|
Application #:
|
16087246
|
Filing Dt:
|
09/21/2018
|
Publication #:
|
|
Pub Dt:
|
02/07/2019
| | | | |
Title:
|
METHODS OF TREATING GASTROINTESTINAL IMMUNE-RELATED ADVERSE EVENTS IN IMMUNE ONCOLOGY TREATMENTS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16135380
|
Filing Dt:
|
09/19/2018
|
Publication #:
|
|
Pub Dt:
|
08/22/2019
| | | | |
Title:
|
Inhibitors of E1 Activating Enzymes
|
|
|
Patent #:
|
|
Issue Dt:
|
01/30/2024
|
Application #:
|
16297990
|
Filing Dt:
|
03/11/2019
|
Publication #:
|
|
Pub Dt:
|
01/30/2020
| | | | |
Title:
|
VEDOLIZUMAB FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE
|
|
|
Patent #:
|
|
Issue Dt:
|
07/19/2022
|
Application #:
|
16309002
|
Filing Dt:
|
12/11/2018
|
Publication #:
|
|
Pub Dt:
|
08/22/2019
| | | | |
Title:
|
METHOD OF TREATING INFLAMMATORY BOWEL DISEASE
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16322244
|
Filing Dt:
|
01/31/2019
|
Publication #:
|
|
Pub Dt:
|
06/27/2019
| | | | |
Title:
|
COMBINATION OF PROTEASOME INHIBITORS AND ANTI-CD30 ANTIBODIES
|
|
|
Patent #:
|
|
Issue Dt:
|
12/15/2020
|
Application #:
|
16348940
|
Filing Dt:
|
05/10/2019
|
Publication #:
|
|
Pub Dt:
|
12/19/2019
| | | | |
Title:
|
ATG7 INHIBITORS AND THE USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
10/11/2022
|
Application #:
|
16349499
|
Filing Dt:
|
05/13/2019
|
Publication #:
|
|
Pub Dt:
|
09/26/2019
| | | | |
Title:
|
NON-ADULT HUMAN DOSING OF BRENTUXIMAB VEDOTIN
|
|
|
Patent #:
|
|
Issue Dt:
|
09/22/2020
|
Application #:
|
16391534
|
Filing Dt:
|
04/23/2019
|
Publication #:
|
|
Pub Dt:
|
03/19/2020
| | | | |
Title:
|
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
|
|
|
Patent #:
|
|
Issue Dt:
|
03/07/2023
|
Application #:
|
16455103
|
Filing Dt:
|
06/27/2019
|
Publication #:
|
|
Pub Dt:
|
05/21/2020
| | | | |
Title:
|
PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN ANTIBODY
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16467524
|
Filing Dt:
|
06/07/2019
|
Publication #:
|
|
Pub Dt:
|
12/05/2019
| | | | |
Title:
|
CONFORMAL COATING OF BIOLOGICAL SURFACES
|
|
|
Patent #:
|
|
Issue Dt:
|
12/21/2021
|
Application #:
|
16610863
|
Filing Dt:
|
11/04/2019
|
Publication #:
|
|
Pub Dt:
|
05/21/2020
| | | | |
Title:
|
TREATMENT OF GASTROPARESIS WITH TRIAZASPIRO[4.5]DECANONE
|
|
|
Patent #:
|
|
Issue Dt:
|
09/21/2021
|
Application #:
|
16648893
|
Filing Dt:
|
03/19/2020
|
Publication #:
|
|
Pub Dt:
|
09/03/2020
| | | | |
Title:
|
COCRYSTAL FORMS OF ((1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-PYRROLO [2,3-D]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL) METHYL SULFAMATE, FORMULATIONS AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
08/16/2022
|
Application #:
|
16751107
|
Filing Dt:
|
01/23/2020
|
Publication #:
|
|
Pub Dt:
|
07/23/2020
| | | | |
Title:
|
ANTI-CD38 BINDING DOMAINS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16766397
|
Filing Dt:
|
05/22/2020
|
Publication #:
|
|
Pub Dt:
|
12/03/2020
| | | | |
Title:
|
BIOMARKERS AND METHODS FOR TREATMENT WITH NAE INHIBITORS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16855863
|
Filing Dt:
|
04/22/2020
|
Publication #:
|
|
Pub Dt:
|
03/11/2021
| | | | |
Title:
|
Inhibitors of E1 activating enzymes
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17059026
|
Filing Dt:
|
11/25/2020
|
Publication #:
|
|
Pub Dt:
|
07/08/2021
| | | | |
Title:
|
SYSTEMS AND METHODS FOR AUTOMATED TRACKING AND OPTIMIZATION OF GLOBAL MANUFACTURING AND SUPPLY BASED ON IMPACTS OF POST-APPROVAL CHANGES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17258845
|
Filing Dt:
|
01/08/2021
|
Publication #:
|
|
Pub Dt:
|
09/02/2021
| | | | |
Title:
|
ADMINISTRATION OF SUMO-ACTIVATING ENZYME INHIBITOR AND ANTI-CD20 ANTIBODIES
|
|